News
SNZZF
0.700
NaN%
--
Senzime Launches TetraAnalytics to Expand TetraGraph Neuromuscular Monitoring Ecosystem
TipRanks · 4d ago
Senzime Wins Major U.S. Pediatric Contract as New Data Backs Cost-Saving Anesthesia Monitoring
TipRanks · 6d ago
BRIEF-Senzime Secures Contract With U.S. Hospital
Reuters · 6d ago
Senzime launches more sustainable EMG sensor for TetraGraph anesthesia monitoring
TipRanks · 06/01 09:36
Senzime Wins Expanded FDA Clearance for Enhanced TetraGraph Monitoring System
TipRanks · 05/27 09:33
Senzime AB Sees Q1 Dip but Growth Intact
TipRanks · 05/20 07:46
Senzime AGM Approves New Share Classes, Incentive Schemes and Capital Mandate
TipRanks · 05/19 16:08
Senzime bolsters U.S. leadership to drive anesthesia-monitoring growth
TipRanks · 04/29 12:32
Senzime Wins US GPO Deals to Accelerate TetraGraph Hospital Adoption
TipRanks · 04/24 12:03
BRIEF-Senzime's TetraGraph System Contracted On Three GPO Agreements In U.S.
Reuters · 04/24 11:35
Senzime publishes 2025 annual and sustainability report
PUBT · 04/24 10:20
Senzime AB Earnings Call: Growth Paused, Momentum Intact
TipRanks · 04/23 00:34
Senzime AB (publ) reports Q1 results
Seeking Alpha · 04/22 17:24
Senzime Lifts Margins and Cash Flow Despite Temporary Growth Slowdown
TipRanks · 04/22 06:45
Senzime Q1 operating loss narrows 3.1% to SEK -20.2 million
PUBT · 04/22 06:04
BRIEF-Senzime Q1 Operating Expenses SEK 35.562 Million
Reuters · 04/22 06:00
Senzime Expands TetraGraph Footprint with Major Southeastern US Hospital Contract
TipRanks · 04/20 07:36
BRIEF-Senzime Wins Expanded Contract Within U.S. Hospital System
Reuters · 04/20 07:01
Senzime Calls 2026 AGM With Governance and Incentive Plans on the Agenda
TipRanks · 04/17 16:03
Senzime announces annual general meeting
PUBT · 04/17 15:35
More
Webull provides a variety of real-time SNZZF stock news. You can receive the latest news about Senzime Ab through multiple platforms. This information may help you make smarter investment decisions.
About SNZZF
Senzime AB (publ.) is a Sweden-based company engaged in the development, manufacture and marketing of biosensors for measuring metabolites in biological fluids, such as human blood and cell culture substrates for the pharmaceutical and healthcare segments. The Company focuses on the following application areas: medical diagnostic instruments, pharmaceutical industry, chemical processing, and food and beverage processing. As of December 31, 2011, the Company marketed three products, namely SENZ-100G, for continuous analysis of glucose in the fermentation solutions; SENZ-100L, for continuous analysis of lactate in fermentation solutions, and SENZ-200G, for continuous analysis of glucose in blood during intensive care.